Skip to content

Sodium phenylbutyrate

Buphenyl, Ammonaps, Pheburane (sodium phenylbutyrate) is a small molecule pharmaceutical. Sodium phenylbutyrate was first approved as Buphenyl on 1996-04-30. It is used to treat beta-thalassemia, cystic fibrosis, myeloproliferative disorders, and sickle cell anemia in the USA. It has been approved in Europe to treat carbamoyl-phosphate synthase i deficiency disease, citrullinemia, and ornithine carbamoyltransferase deficiency disease.
Trade Name Ammonaps, Pheburane
Common Name Sodium phenylbutyrate
Indication beta-thalassemia, carbamoyl-phosphate synthase i deficiency disease, citrullinemia, cystic fibrosis, myeloproliferative disorders, ornithine carbamoyltransferase deficiency disease, sickle cell anemia
Drug Class
Sodium phenylbutyrate
Get full access now